Responses
Inflammatory bowel disease
Original article
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts
Compose a Response to This Article
Other responses
No responses have been published for this article.